Innovation Observatory > Reports > Drugs > Voxelotor for Sickle Cell Disease

< Back

Voxelotor for Sickle Cell Disease


Haematology and Blood Products

November 2017

Voxelotor is as an oral, once-daily therapy that is being developed for treatment of SCD. It is designed to work by helping haemoglobin hold onto more oxygen as the red blood cells travel through the body. This keeps red blood cells in their normal shape and helps stop sickling. As there is a desperate need for new treatments for SCD, voxelotor, if licensed, will offer a new treatment option for patients with SCD.

Innovation Observatory Voice 0

Leave a Reply

Your email address will not be published. Required fields are marked *

Post Comment

Voxelotor for Sickle Cell Disease


Connect to the Innovation Observatory


Load More Related Posts
Get Alerts